Dongwha Pharm.Co.,Ltd (KRX:000020)

South Korea · Delayed Price · Currency is KRW

6,110.00

+450.00 (7.95%)

At close: Mar 5, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012	FY 2011
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011
Pharmaceutical Industry	363.80B	335.14B	315.93B	272.21B	267.44B
Pharmaceutical Industry Growth	8.55%	6.08%	16.06%	1.79%	-12.93%
Medical Equipment Manufacturing	25.50B	26.56B	24.61B	20.80B	4.64B
Medical Equipment Manufacturing Growth	-4.01%	7.91%	18.31%	348.72%	-
Consolidation Adjustment	-66.81M	-587.46M	-115.92M	-	-
Medicines Distribution Chain	75.65B	-	-	-	-
Total	464.87B	361.11B	340.43B	293.02B	272.08B
Total Growth	28.74%	6.08%	16.18%	7.70%	-11.42%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2012	FY 2011
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011
South Korea	364.81B	342.94B	321.93B	278.55B	266.22B
South Korea Growth	6.38%	6.53%	15.57%	4.63%	-12.10%
Overseas	100.07B	18.17B	18.50B	14.47B	5.86B
Overseas Growth	450.64%	-1.77%	27.85%	147.13%	37.14%
Total	464.87B	361.11B	340.43B	293.02B	272.08B
Total Growth	28.74%	6.08%	16.18%	7.70%	-11.42%

Source: S&P Global Market Intelligence.